新型磷结合剂、维生素D类似物及钙敏感受体激活剂等现已陆续进入临床,并取得良好疗效。
The therapeutic effects of new type phosphate binder, vitamin D analogue and calcimimetic compound have been evidenced already.
目的探讨白三烯(LT)B4能否不依赖细胞核因子资B受体激活剂配体(RANKL)直接促进人破骨细胞的分化和激活。
Objective To determine whether leukotriene B4 (LTB4) could directly stimulate human osteoclast differentiation and activation independent of RANKL (ODF).
应用推荐